Consistent with previous reports, we revealed that the relationship between Th17/IL-17 and disease stage, and speculated that the mechanisms of immune disorders and inflammatory reaction in the course of the MM, nevertheless further study need to expand the sample size and ascertain the critical role of Th17/IL-17 as a prognostic maker for MM. This evidence concerns the gene IL17A and Miyoshi myopathy.